{"_self":{"principle":"Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.","widget":"article_voxels","feature":"voxels","name":"Voxel graph","what":"Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance.","contains":"claim voxels + source edges","slug":"vip-neuropathy","urls":{"read":"https://miscsubjects.com/api/articles/vip-neuropathy/voxels","write":"https://miscsubjects.com/api/protocol/claim"},"how_to_use":"Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance.","write":"https://miscsubjects.com/api/protocol/claim","imessage":null,"router_tag":null,"proof_chain":[{"step":1,"claim":"Articles are voxel graphs of tiered claims, not prose blobs.","verify":"https://miscsubjects.com/api/articles/constitution"},{"step":2,"claim":"Claims link to hash-chained sources via source_ids.","verify":"https://miscsubjects.com/api/articles/vip-neuropathy/sources"},{"step":3,"claim":"Ask reads topology; ingest/claim append to ledger.","verify":"https://miscsubjects.com/api/protocol"},{"step":4,"claim":"Models queue growth: populate → collaborate → repair → reflex.","verify":"https://miscsubjects.com/api/protocol/grow"},{"step":5,"claim":"Graph proves its own shape (reflex) and $/claim (yield).","verify":"https://miscsubjects.com/graph.html?layer=reflex"},{"step":6,"claim":"Full feature index + _explain on every API response.","verify":"https://miscsubjects.com/api/articles/system-map"}],"related_features":[{"id":"constitution","name":"Article constitution","what":"Binding rules: required article slots, claim/source rules, ontology anti-sprawl.","urls":{"read":"https://miscsubjects.com/api/articles/constitution","read_md":"https://miscsubjects.com/api/articles/constitution?format=markdown"}},{"id":"sources_ledger","name":"Source ledger","what":"Hash-chained cited sources; verify integrity at GET .../sources.","urls":{"read":"https://miscsubjects.com/api/articles/vip-neuropathy/sources","write":"https://miscsubjects.com/api/protocol/sources"}},{"id":"claim_post","name":"Claim post protocol","what":"Prompt-injection style POST — one claim voxel with who_claims + posted_by.","urls":{"read":"https://miscsubjects.com/api/articles/vip-neuropathy/voxels","write":"https://miscsubjects.com/api/protocol/claim"}}],"system_map":"https://miscsubjects.com/api/articles/system-map","system_map_markdown":"https://miscsubjects.com/api/articles/system-map?format=markdown","not_medical_advice":true},"_explain":{"feature":"voxels","name":"Voxel graph","what":"Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance.","why":"Every feature is auditable collective intelligence","how":"Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance.","model":null,"verifies":null,"urls":{"read":"https://miscsubjects.com/api/articles/vip-neuropathy/voxels","write":"https://miscsubjects.com/api/protocol/claim"},"imessage":null,"router":null,"related":[{"id":"constitution","what":"Binding rules: required article slots, claim/source rules, ontology anti-sprawl."},{"id":"sources_ledger","what":"Hash-chained cited sources; verify integrity at GET .../sources."},{"id":"claim_post","what":"Prompt-injection style POST — one claim voxel with who_claims + posted_by."}],"not_medical_advice":true},"position":{"you_are_here":"https://miscsubjects.com/a/vip-neuropathy — VIP for Neuropathy: Evidence-Graded Look at Immune and Autonomic Layers","plane":"vip","master_entry":"https://miscsubjects.com/a/philosophy","siblings":[{"slug":"vip","title":"vip","url":"https://miscsubjects.com/a/vip"},{"slug":"vip-benzo-withdrawal","title":"VIP for Benzodiazepine Withdrawal: Evidence Review","url":"https://miscsubjects.com/a/vip-benzo-withdrawal"},{"slug":"vip-benzodiazepines","title":"VIP and Benzodiazepines: Immune and Autonomic Pathways in a Suppression Context","url":"https://miscsubjects.com/a/vip-benzodiazepines"},{"slug":"vip-brain-fog","title":"VIP for Statin-Associated Cognitive Effects: Evidence Review","url":"https://miscsubjects.com/a/vip-brain-fog"},{"slug":"vip-carpal-tunnel","title":"VIP for Carpal Tunnel Syndrome: A Data-First Evidence Review","url":"https://miscsubjects.com/a/vip-carpal-tunnel"},{"slug":"vip-chemo","title":"VIP Peptide for Chemotherapy Contexts: Evidence on Immune and Autonomic Layers","url":"https://miscsubjects.com/a/vip-chemo"},{"slug":"vip-chemo-neuropathy","title":"VIP for Chemotherapy-Induced Neuropathy: A Data-First Evidence Review","url":"https://miscsubjects.com/a/vip-chemo-neuropathy"},{"slug":"vip-cognition","title":"VIP for Cognition: Evidence on Vasoactive Intestinal Peptide","url":"https://miscsubjects.com/a/vip-cognition"},{"slug":"vip-corticosteroids","title":"VIP and Corticosteroid Injections: Evidence Layers on Immune Modulation and Repair Trade-offs","url":"https://miscsubjects.com/a/vip-corticosteroids"},{"slug":"vip-diabetic-neuropathy","title":"VIP for Diabetic Neuropathy: Evidence-Graded Overview","url":"https://miscsubjects.com/a/vip-diabetic-neuropathy"},{"slug":"vip-frozen-shoulder","title":"VIP for Frozen Shoulder: Evidence Review","url":"https://miscsubjects.com/a/vip-frozen-shoulder"},{"slug":"vip-gabapentin","title":"VIP Peptide Evidence for Gabapentin Users: Immune and Autonomic Layers","url":"https://miscsubjects.com/a/vip-gabapentin"},{"slug":"vip-glp-1","title":"VIP Peptide in the Context of GLP-1 Agonists: Layered Evidence on Immune, Autonomic, and Metabolic Pathways","url":"https://miscsubjects.com/a/vip-glp-1"},{"slug":"vip-glp1-gut","title":"VIP Peptide and GLP-1 Agonist Gut Effects: Evidence on Motility and Repair Layers","url":"https://miscsubjects.com/a/vip-glp1-gut"},{"slug":"vip-gut","title":"VIP for Gut: Evidence-Graded Look at Vasoactive Intestinal Peptide","url":"https://miscsubjects.com/a/vip-gut"},{"slug":"vip-herniated-disc","title":"VIP for Herniated Disc: Evidence on Repair Pathways","url":"https://miscsubjects.com/a/vip-herniated-disc"},{"slug":"vip-ibd","title":"VIP for IBD: Evidence Graded Review of Vasoactive Intestinal Peptide in Crohn's Disease and Colitis","url":"https://miscsubjects.com/a/vip-ibd"},{"slug":"vip-insomnia","title":"VIP for Insomnia: Preclinical Evidence and Context for Autonomic and Immune Layers","url":"https://miscsubjects.com/a/vip-insomnia"},{"slug":"vip-metformin","title":"VIP × Metformin","url":"https://miscsubjects.com/a/vip-metformin"},{"slug":"vip-muscle-loss","title":"VIP for Muscle Loss: Preclinical Signals on Vasoactive Intestinal Peptide","url":"https://miscsubjects.com/a/vip-muscle-loss"},{"slug":"vip-nerve-damage","title":"VIP for Nerve Damage: Preclinical Signals on Vasoactive Intestinal Peptide","url":"https://miscsubjects.com/a/vip-nerve-damage"},{"slug":"vip-nsaids","title":"VIP and NSAIDs: Preclinical Immune Modulation Data vs Inflammation Suppression","url":"https://miscsubjects.com/a/vip-nsaids"},{"slug":"vip-ozempic-face","title":"VIP for Ozempic Face: Graded Evidence on Facial Collagen and Volume Loss After GLP-1 Use","url":"https://miscsubjects.com/a/vip-ozempic-face"},{"slug":"vip-plantar-fasciitis","title":"VIP for Plantar Fasciitis: Immune Modulation and Tissue Repair Pathways","url":"https://miscsubjects.com/a/vip-plantar-fasciitis"},{"slug":"vip-post-surgery","title":"VIP for Post-Surgery Recovery: Evidence-Graded Review","url":"https://miscsubjects.com/a/vip-post-surgery"},{"slug":"vip-postherpetic","title":"VIP for Postherpetic Neuralgia: Evidence Review","url":"https://miscsubjects.com/a/vip-postherpetic"},{"slug":"vip-ppis","title":"VIP for PPIs: Evidence on Vasoactive Intestinal Peptide and Proton Pump Inhibitors","url":"https://miscsubjects.com/a/vip-ppis"},{"slug":"vip-sciatica","title":"VIP for Sciatica: Repair Layers and the Evidence on VIP, BPC-157, TB-500, ARA-290","url":"https://miscsubjects.com/a/vip-sciatica"},{"slug":"vip-semaglutide","title":"VIP and Semaglutide: Layered Evidence on Immune/Autonomic and Metabolic Repair Pathways","url":"https://miscsubjects.com/a/vip-semaglutide"},{"slug":"vip-skin","title":"VIP for Skin: Evidence-Graded Look at Vasoactive Intestinal Peptide Research","url":"https://miscsubjects.com/a/vip-skin"},{"slug":"vip-statins","title":"VIP for Statins: Immune and Autonomic Repair Pathways in Context","url":"https://miscsubjects.com/a/vip-statins"},{"slug":"vip-stimulants","title":"VIP and Supporting Peptides for Stimulant Load: Evidence-Graded Review","url":"https://miscsubjects.com/a/vip-stimulants"},{"slug":"vip-tendon","title":"VIP for Tendon Repair: What the Data Shows","url":"https://miscsubjects.com/a/vip-tendon"},{"slug":"vip-tirzepatide","title":"VIP and Tirzepatide: Layered Evidence on Immune/Autonomic and Metabolic Pathways","url":"https://miscsubjects.com/a/vip-tirzepatide"},{"slug":"vip-trigeminal","title":"VIP for Trigeminal Issues: Evidence on Repair Pathways","url":"https://miscsubjects.com/a/vip-trigeminal"}],"machine_side":"https://miscsubjects.com/api/articles/vip-neuropathy/voxels","discourse":"https://miscsubjects.com/api/articles/vip-neuropathy/discourse","append_protocol":"https://miscsubjects.com/a/append-protocol","protocol_door":"https://miscsubjects.com/api/protocol"},"slug":"vip-neuropathy","div_mode":true,"voxel":{"mode":"div","divided_at":"2026-07-17T02:43:25.649Z","divided_by":"owner","original_body_sha":"1522572c50579896e93ac550d3bc09b96670fa6809c31e4df1c303508206ab25","atoms":22,"version":1},"divs":[{"id":"d1","kind":"h","type":null,"order":1,"text":"## What's breaking down","status":"active","vx_hash":"1b87628fd40239765e8587bb64cf4c8b99527482508bc910e4484e035cf8e7a9","semantic_hash":null,"version_hash":null,"version":1,"sources":[],"falsifiers":[],"tier":null,"backed":null,"transcludes":null,"chain_head":"700b45ebd3af74e37b45841062a171aa029e2254968e00119592bbd7a79a5b79","chain_length":1,"chain":[{"n":1,"op":"genesis","ts":"2026-07-17T02:43:25.649Z","actor":"owner","text_sha":"b29f40c743ed444dcc2d5fa631df4a3d833923560a7f1bab96a896384badae8a","detail":{"divided_from":"body","block":1,"kind":"h"},"prev":"genesis","hash":"700b45ebd3af74e37b45841062a171aa029e2254968e00119592bbd7a79a5b79"}],"claim_ids":[],"last_op":{"op":"genesis","actor":"owner","ts":"2026-07-17T02:43:25.649Z"},"consolidated_into":null,"stable_url":"https://miscsubjects.com/i/div/vip-neuropathy/d1"},{"id":"d2","kind":"p","type":null,"order":2,"text":"Neuropathy involves progressive loss of nerve structure and function. Peripheral nerves lose myelin, axons degenerate, and inflammation persists in the nerve environment. Schwann cells that support myelin fail to repair damage quickly enough. Immune cells like macrophages stay activated and release cytokines that slow recovery. Autonomic nerves that control blood flow and organ signals can also show altered peptide expression. When repair pathways lag behind ongoing breakdown, symptoms continue. VIP is discussed in this context because studies examine its effects on immune balance and nerve-support cells rather than direct symptom masking.","status":"active","vx_hash":"882e6b8ebe6babfdad999cdc287e7cbc991fa75556e7131e90fe65e280ea9353","semantic_hash":null,"version_hash":null,"version":1,"sources":[],"falsifiers":[],"tier":null,"backed":null,"transcludes":null,"chain_head":"930b2478476201eed18a2bb80d4c77235d7f884bb3eb5fc1b225d8da08ce77c9","chain_length":1,"chain":[{"n":1,"op":"genesis","ts":"2026-07-17T02:43:25.649Z","actor":"owner","text_sha":"255cee137c6c85e79379f77c62f6767bf60f29ac38696610838bcc7dba4ae312","detail":{"divided_from":"body","block":2,"kind":"p"},"prev":"genesis","hash":"930b2478476201eed18a2bb80d4c77235d7f884bb3eb5fc1b225d8da08ce77c9"}],"claim_ids":[],"last_op":{"op":"genesis","actor":"owner","ts":"2026-07-17T02:43:25.649Z"},"consolidated_into":null,"stable_url":"https://miscsubjects.com/i/div/vip-neuropathy/d2"},{"id":"d3","kind":"h","type":null,"order":3,"text":"## Why VIP might help you","status":"active","vx_hash":"1f28ede6217470468faf58a0793e7f570e7577abc1b6a50eff2ac1f43422ee21","semantic_hash":null,"version_hash":null,"version":1,"sources":[],"falsifiers":[],"tier":null,"backed":null,"transcludes":null,"chain_head":"0f192d723a0e46adf890afc0d40fe2512802ccfbd24961641b5efed108731b67","chain_length":1,"chain":[{"n":1,"op":"genesis","ts":"2026-07-17T02:43:25.649Z","actor":"owner","text_sha":"2a6ba0f8b2ed4582e06cb2080e8de8e2c0adea0f26a4fbd7054aff027cad5a62","detail":{"divided_from":"body","block":3,"kind":"h"},"prev":"genesis","hash":"0f192d723a0e46adf890afc0d40fe2512802ccfbd24961641b5efed108731b67"}],"claim_ids":[],"last_op":{"op":"genesis","actor":"owner","ts":"2026-07-17T02:43:25.649Z"},"consolidated_into":null,"stable_url":"https://miscsubjects.com/i/div/vip-neuropathy/d3"},{"id":"d4","kind":"p","type":null,"order":4,"text":"If immune activation and autonomic signaling form part of your neuropathy picture, VIP is examined for its potential effects on those layers. The logic runs like this: injured nerves up-regulate VIP expression; VIP acts on receptors present on Schwann cells and immune cells in the nerve stump; those actions shift cytokine profiles toward less inflammation and support myelin-related gene expression. Therefore for you: If that layer is part of your problem, VIP is discussed because it targets repair (tissue) — not because it masks pain.","status":"active","vx_hash":"c3755e5342b25eab5e4d404e7aab02404252dbf2bb50377deec0d1a177bb4b16","semantic_hash":null,"version_hash":null,"version":1,"sources":[],"falsifiers":[],"tier":null,"backed":null,"transcludes":null,"chain_head":"dcb846acd8a8a6937bbcf683dcdf0aad19535a4411842b0ae629650f011b1963","chain_length":1,"chain":[{"n":1,"op":"genesis","ts":"2026-07-17T02:43:25.649Z","actor":"owner","text_sha":"61fd3af396cdecec926224cf311921382ed8846a5014be0c53615030bc3071b2","detail":{"divided_from":"body","block":4,"kind":"p"},"prev":"genesis","hash":"dcb846acd8a8a6937bbcf683dcdf0aad19535a4411842b0ae629650f011b1963"}],"claim_ids":[],"last_op":{"op":"genesis","actor":"owner","ts":"2026-07-17T02:43:25.649Z"},"consolidated_into":null,"stable_url":"https://miscsubjects.com/i/div/vip-neuropathy/d4"},{"id":"d5","kind":"p","type":null,"order":5,"text":"Step 1: Nerve injury triggers local VIP increase in animal models. Step 2: VIP binds VPAC receptors on Schwann cells. Step 3: This binding correlates with higher expression of myelin genes and lower pro-inflammatory signals. Step 4: The net result in explant studies is reduced cytokine output that could otherwise prolong degeneration. The framing stays on repair pathways versus symptom suppression.","status":"active","vx_hash":"7a0a14c4570b55d29986d4d36bff52ff84157b5e658654d7bb62bab82136ac7a","semantic_hash":null,"version_hash":null,"version":1,"sources":[],"falsifiers":[],"tier":null,"backed":null,"transcludes":null,"chain_head":"9190229f98757fc1f19aad8087208b1ed44b71d49c5affda8ff2b8487a22d7ea","chain_length":1,"chain":[{"n":1,"op":"genesis","ts":"2026-07-17T02:43:25.649Z","actor":"owner","text_sha":"0feb6b94ccdd01a31900f6bd6833f9afcc22b45d8fa4b57fcef394bf2f76daaf","detail":{"divided_from":"body","block":5,"kind":"p"},"prev":"genesis","hash":"9190229f98757fc1f19aad8087208b1ed44b71d49c5affda8ff2b8487a22d7ea"}],"claim_ids":[],"last_op":{"op":"genesis","actor":"owner","ts":"2026-07-17T02:43:25.649Z"},"consolidated_into":null,"stable_url":"https://miscsubjects.com/i/div/vip-neuropathy/d5"},{"id":"d6","kind":"h","type":null,"order":6,"text":"## How these fit together","status":"active","vx_hash":"99fa34fe0f184df15245bdd6179287e2495609255e55f79e62028fefb3b6a674","semantic_hash":null,"version_hash":null,"version":1,"sources":[],"falsifiers":[],"tier":null,"backed":null,"transcludes":null,"chain_head":"03c1cb5893eb8cbd46f4c5a95f6046485d217a2125057e2c330dbf1e2747f43d","chain_length":1,"chain":[{"n":1,"op":"genesis","ts":"2026-07-17T02:43:25.649Z","actor":"owner","text_sha":"255677f13849515d0e42f067e34911236d8b3298d6c16100bfa19e68c3074d62","detail":{"divided_from":"body","block":6,"kind":"h"},"prev":"genesis","hash":"03c1cb5893eb8cbd46f4c5a95f6046485d217a2125057e2c330dbf1e2747f43d"}],"claim_ids":[],"last_op":{"op":"genesis","actor":"owner","ts":"2026-07-17T02:43:25.649Z"},"consolidated_into":null,"stable_url":"https://miscsubjects.com/i/div/vip-neuropathy/d6"},{"id":"d7","kind":"p","type":null,"order":7,"text":"Single-compound focus. VIP maps to the immune / autonomic layer. Any broader stack would assign other peptides to separate layers such as direct axon growth or sleep-related recovery. Here the emphasis remains on VIP's studied actions in the nerve microenvironment.","status":"active","vx_hash":"2ce339bbf257f22269d40b2012bbd77120051ee77cc8d0ebbc2f3d4059d81a5b","semantic_hash":null,"version_hash":null,"version":1,"sources":[],"falsifiers":[],"tier":null,"backed":null,"transcludes":null,"chain_head":"da3f5d2121f40a135b8b71c5cfb4faf4c0f13c4c2b9afbb76a3710b1d222b8bd","chain_length":1,"chain":[{"n":1,"op":"genesis","ts":"2026-07-17T02:43:25.649Z","actor":"owner","text_sha":"bb88dff88974926640babe2bbca9172449fdf7f6ce373d216b8aa71bf304f1f1","detail":{"divided_from":"body","block":7,"kind":"p"},"prev":"genesis","hash":"da3f5d2121f40a135b8b71c5cfb4faf4c0f13c4c2b9afbb76a3710b1d222b8bd"}],"claim_ids":[],"last_op":{"op":"genesis","actor":"owner","ts":"2026-07-17T02:43:25.649Z"},"consolidated_into":null,"stable_url":"https://miscsubjects.com/i/div/vip-neuropathy/d7"},{"id":"d8","kind":"h","type":null,"order":8,"text":"## What the evidence actually shows","status":"active","vx_hash":"cc4ebc3460a9c2cbb8449cc93ed6fd5084508f247dbbd0fa81115f8b97b95f53","semantic_hash":null,"version_hash":null,"version":1,"sources":[],"falsifiers":[],"tier":null,"backed":null,"transcludes":null,"chain_head":"ef53ca18ad231c87a8d6f7988900b9148cf50a4ba9a466be9bcc648d8eb1de5d","chain_length":1,"chain":[{"n":1,"op":"genesis","ts":"2026-07-17T02:43:25.649Z","actor":"owner","text_sha":"a7a051e6a294dc45c15b7d4859b7020d561e719fe73844f03e3a8f9e7fed8de1","detail":{"divided_from":"body","block":8,"kind":"h"},"prev":"genesis","hash":"ef53ca18ad231c87a8d6f7988900b9148cf50a4ba9a466be9bcc648d8eb1de5d"}],"claim_ids":[],"last_op":{"op":"genesis","actor":"owner","ts":"2026-07-17T02:43:25.649Z"},"consolidated_into":null,"stable_url":"https://miscsubjects.com/i/div/vip-neuropathy/d8"},{"id":"d9","kind":"p","type":null,"order":9,"text":"Preclinical (animal) data form the main body of findings. In a 2019 mouse sciatic nerve transection study, VIP and PACAP treatment of cultured Schwann cells increased myelin gene expression and reduced release of TNFα, IL-1β, and other pro-inflammatory cytokines after stimulation. The same compounds lowered cytokine output in sciatic nerve explants. Receptors VPAC1, VPAC2, and PAC1 were upregulated in the distal nerve stump after injury. This is preclinical evidence from rat Schwann cell cultures and mouse nerve explants (source s1). An earlier rat study measured changes in VIP immunoreactivity after nerve injury and linked it to regeneration processes (source s2). Another rat neuron culture experiment showed VIP rescued myenteric neurons from LPS-induced cell death (source s3).","status":"active","vx_hash":"52b8e7998975292c7f4c6e21569da12e5c9adf41ed2e094d92ab6144acf3b1d7","semantic_hash":null,"version_hash":null,"version":1,"sources":[],"falsifiers":[],"tier":null,"backed":null,"transcludes":null,"chain_head":"3778be005169ea17a8609288233e167150fa63b3880ebda7bc929ed242040c1e","chain_length":1,"chain":[{"n":1,"op":"genesis","ts":"2026-07-17T02:43:25.649Z","actor":"owner","text_sha":"dac83f1d80b5327e19b8bfb8eab80f025f9a0471fd2c3e36b70f214bf5e8acca","detail":{"divided_from":"body","block":9,"kind":"p"},"prev":"genesis","hash":"3778be005169ea17a8609288233e167150fa63b3880ebda7bc929ed242040c1e"}],"claim_ids":[],"last_op":{"op":"genesis","actor":"owner","ts":"2026-07-17T02:43:25.649Z"},"consolidated_into":null,"stable_url":"https://miscsubjects.com/i/div/vip-neuropathy/d9"},{"id":"d10","kind":"p","type":null,"order":10,"text":"Human data specific to peripheral neuropathy treatment with VIP are absent. One 2025 study measured serum VIP in multiple sclerosis patients and found levels significantly lower than controls (preclinical-adjacent human observation, source s4). MS can involve neuropathic features, but the study did not test VIP administration for symptom relief. No randomized human trials of VIP for diabetic, chemotherapy-induced, or idiopathic neuropathy appear in the searched literature.","status":"active","vx_hash":"0350dc2800f00def5f0c050d2de343136378d1b21b3c63610068551606134178","semantic_hash":null,"version_hash":null,"version":1,"sources":[],"falsifiers":[],"tier":null,"backed":null,"transcludes":null,"chain_head":"9b3147059d91574f44cec9e70d85dd71d7222bd211f98cd6a1f9affa89144dd6","chain_length":1,"chain":[{"n":1,"op":"genesis","ts":"2026-07-17T02:43:25.649Z","actor":"owner","text_sha":"b6c7d0887282e8651259efe845cf53110e78cd3fa0a8896efccc47255deef55b","detail":{"divided_from":"body","block":10,"kind":"p"},"prev":"genesis","hash":"9b3147059d91574f44cec9e70d85dd71d7222bd211f98cd6a1f9affa89144dd6"}],"claim_ids":[],"last_op":{"op":"genesis","actor":"owner","ts":"2026-07-17T02:43:25.649Z"},"consolidated_into":null,"stable_url":"https://miscsubjects.com/i/div/vip-neuropathy/d10"},{"id":"d11","kind":"p","type":null,"order":11,"text":"Anecdotal reports on forums center on VIP as a chemotherapy regimen (etoposide, ifosfamide, cisplatin) rather than the peptide itself; those posts discuss chemo-related neuropathy incidence (source s5). A single Reddit thread describes general VIP peptide functions without neuropathy-specific user experience (source s6).","status":"active","vx_hash":"7c0011fb930a6aa6e00153bf8e0acc3ac9a8788c78967bc22c924fc27345d9fa","semantic_hash":null,"version_hash":null,"version":1,"sources":[],"falsifiers":[],"tier":null,"backed":null,"transcludes":null,"chain_head":"f6295608bb7082b14555542a8235b3a03d853d94c01fc8c0cbff0795103ac369","chain_length":1,"chain":[{"n":1,"op":"genesis","ts":"2026-07-17T02:43:25.649Z","actor":"owner","text_sha":"2d540d314e0cd7fe5d90b21c64fdd8aadc515b1952ca8c0a3a69991ffda08b99","detail":{"divided_from":"body","block":11,"kind":"p"},"prev":"genesis","hash":"f6295608bb7082b14555542a8235b3a03d853d94c01fc8c0cbff0795103ac369"}],"claim_ids":[],"last_op":{"op":"genesis","actor":"owner","ts":"2026-07-17T02:43:25.649Z"},"consolidated_into":null,"stable_url":"https://miscsubjects.com/i/div/vip-neuropathy/d11"},{"id":"d12","kind":"h","type":null,"order":12,"text":"## What scientists say","status":"active","vx_hash":"80ab84d69b7b292d1a6ba46fd6fddc4809486f9920cd37e07384a5a461dc1902","semantic_hash":null,"version_hash":null,"version":1,"sources":[],"falsifiers":[],"tier":null,"backed":null,"transcludes":null,"chain_head":"e602868df701e6e7f6569f07efd9d9539a5b8d30b7040ac6f115ebdc8f7547fb","chain_length":1,"chain":[{"n":1,"op":"genesis","ts":"2026-07-17T02:43:25.649Z","actor":"owner","text_sha":"2f1dd55083de1fa734f2f06a8337a050d5a0b3f635bfc8bb709abab75705a1ef","detail":{"divided_from":"body","block":12,"kind":"h"},"prev":"genesis","hash":"e602868df701e6e7f6569f07efd9d9539a5b8d30b7040ac6f115ebdc8f7547fb"}],"claim_ids":[],"last_op":{"op":"genesis","actor":"owner","ts":"2026-07-17T02:43:25.649Z"},"consolidated_into":null,"stable_url":"https://miscsubjects.com/i/div/vip-neuropathy/d12"},{"id":"d13","kind":"p","type":null,"order":13,"text":"Researchers note VIP's upregulation after peripheral nerve injury in rodent models and its paracrine effects on Schwann cells and macrophages that favor remyelination and inflammation resolution (source s1). Reviews highlight VIP's broader immunomodulatory profile in autoimmune and inflammatory settings, including arthritis models, but call for more targeted neuropathy work (source s7). Human biomarker studies in conditions with neuropathic overlap show altered VIP levels, yet direct causation or therapeutic translation remains unproven.","status":"active","vx_hash":"c25f631d7a05967f969faf8bbb081e9f4cbcf17d7749730849441d927fdfa068","semantic_hash":null,"version_hash":null,"version":1,"sources":[],"falsifiers":[],"tier":null,"backed":null,"transcludes":null,"chain_head":"6fb7516d0ce34d905096f253ac29b06c3542d33bb77049645c2151392186d562","chain_length":1,"chain":[{"n":1,"op":"genesis","ts":"2026-07-17T02:43:25.649Z","actor":"owner","text_sha":"39bfbabcdd2eeb056b1046d0f6a1ba61a8997a51b246381e4eab58e9823e4169","detail":{"divided_from":"body","block":13,"kind":"p"},"prev":"genesis","hash":"6fb7516d0ce34d905096f253ac29b06c3542d33bb77049645c2151392186d562"}],"claim_ids":[],"last_op":{"op":"genesis","actor":"owner","ts":"2026-07-17T02:43:25.649Z"},"consolidated_into":null,"stable_url":"https://miscsubjects.com/i/div/vip-neuropathy/d13"},{"id":"d14","kind":"h","type":null,"order":14,"text":"## What people say on Reddit","status":"active","vx_hash":"a871b6b95ad5d80b8257ef85d2566ca1033fb8b238c1fc584e21ec7862fabeb5","semantic_hash":null,"version_hash":null,"version":1,"sources":[],"falsifiers":[],"tier":null,"backed":null,"transcludes":null,"chain_head":"a29fcc55c0c887f44c867d652dc6609d69fe313f2440164701c6502b2fa89541","chain_length":1,"chain":[{"n":1,"op":"genesis","ts":"2026-07-17T02:43:25.649Z","actor":"owner","text_sha":"feb303756a303788527cf602bf2c3c6b00ab8c384fb9fff4baa9ffc53e0049c3","detail":{"divided_from":"body","block":14,"kind":"h"},"prev":"genesis","hash":"a29fcc55c0c887f44c867d652dc6609d69fe313f2440164701c6502b2fa89541"}],"claim_ids":[],"last_op":{"op":"genesis","actor":"owner","ts":"2026-07-17T02:43:25.649Z"},"consolidated_into":null,"stable_url":"https://miscsubjects.com/i/div/vip-neuropathy/d14"},{"id":"d15","kind":"p","type":null,"order":15,"text":"Discussions of VIP peptide for neuropathy are sparse. Most mentions of \"VIP\" in neuropathy threads refer to the chemotherapy protocol and its known risk of dose-dependent neuropathy occurring in 20-40% of patients. One post on peptide uses quotes literature on VIP as a neuropeptide with neuronal and immune roles but offers no personal neuropathy outcome data.","status":"active","vx_hash":"a1a84841f537be1ec68479a493e7de1533bbe424b75838818a7f2fc28fffbf6d","semantic_hash":null,"version_hash":null,"version":1,"sources":[],"falsifiers":[],"tier":null,"backed":null,"transcludes":null,"chain_head":"7453526beb48782da005b35ea887028da4eb0c0c0aa8df6c421e6575021c0ce6","chain_length":1,"chain":[{"n":1,"op":"genesis","ts":"2026-07-17T02:43:25.649Z","actor":"owner","text_sha":"9e740042f97262f13b35a5bbb3b93db2106e1261e2908f7b5523586a1ec8d92b","detail":{"divided_from":"body","block":15,"kind":"p"},"prev":"genesis","hash":"7453526beb48782da005b35ea887028da4eb0c0c0aa8df6c421e6575021c0ce6"}],"claim_ids":[],"last_op":{"op":"genesis","actor":"owner","ts":"2026-07-17T02:43:25.649Z"},"consolidated_into":null,"stable_url":"https://miscsubjects.com/i/div/vip-neuropathy/d15"},{"id":"d16","kind":"h","type":null,"order":16,"text":"## What people say on X","status":"active","vx_hash":"ef96ee53980ca04c79bf52826a8be90deb4eba0f4e6db8501359f68bf75a3aed","semantic_hash":null,"version_hash":null,"version":1,"sources":[],"falsifiers":[],"tier":null,"backed":null,"transcludes":null,"chain_head":"37181939f9bf47b26b3f555ff3b49802bfae25b661b437978b34ce983942f95b","chain_length":1,"chain":[{"n":1,"op":"genesis","ts":"2026-07-17T02:43:25.649Z","actor":"owner","text_sha":"4dd8bbfdb0452cc6235c2300209b5132daba3913b8f54ab179b1a73109c298dd","detail":{"divided_from":"body","block":16,"kind":"h"},"prev":"genesis","hash":"37181939f9bf47b26b3f555ff3b49802bfae25b661b437978b34ce983942f95b"}],"claim_ids":[],"last_op":{"op":"genesis","actor":"owner","ts":"2026-07-17T02:43:25.649Z"},"consolidated_into":null,"stable_url":"https://miscsubjects.com/i/div/vip-neuropathy/d16"},{"id":"d17","kind":"p","type":null,"order":17,"text":"Public posts linking VIP peptide administration to neuropathy outcomes are not prominent in available searches. Limited discussion exists around VIP's general roles in inflammation or nerve biology.","status":"active","vx_hash":"5f2983bd29d8ef980d4e1d46b9ac2485eaaf65369862b38d7b5afb4e7934b686","semantic_hash":null,"version_hash":null,"version":1,"sources":[],"falsifiers":[],"tier":null,"backed":null,"transcludes":null,"chain_head":"e508a5eee91278e2c57edbef345dffa5162136449f8fe423bd26d5958f7c5c86","chain_length":1,"chain":[{"n":1,"op":"genesis","ts":"2026-07-17T02:43:25.649Z","actor":"owner","text_sha":"370829ffbc7ceb169f7799d64bc8d17bf892743485dd28ed60b162e70a91c5be","detail":{"divided_from":"body","block":17,"kind":"p"},"prev":"genesis","hash":"e508a5eee91278e2c57edbef345dffa5162136449f8fe423bd26d5958f7c5c86"}],"claim_ids":[],"last_op":{"op":"genesis","actor":"owner","ts":"2026-07-17T02:43:25.649Z"},"consolidated_into":null,"stable_url":"https://miscsubjects.com/i/div/vip-neuropathy/d17"},{"id":"d18","kind":"h","type":null,"order":18,"text":"## What we do not know","status":"active","vx_hash":"99c933824e392c483b6ce111fb3cd459e5b9838a53547db4ae321fd5df8560df","semantic_hash":null,"version_hash":null,"version":1,"sources":[],"falsifiers":[],"tier":null,"backed":null,"transcludes":null,"chain_head":"7326ff31f32a86f81176bf93a79c27585592f1edeaa031cf8fdc0d3334783d70","chain_length":1,"chain":[{"n":1,"op":"genesis","ts":"2026-07-17T02:43:25.649Z","actor":"owner","text_sha":"7d96a49fba77f6a48c0321db2ae4180a902beae62e2aac0d23408fbf8333a177","detail":{"divided_from":"body","block":18,"kind":"h"},"prev":"genesis","hash":"7326ff31f32a86f81176bf93a79c27585592f1edeaa031cf8fdc0d3334783d70"}],"claim_ids":[],"last_op":{"op":"genesis","actor":"owner","ts":"2026-07-17T02:43:25.649Z"},"consolidated_into":null,"stable_url":"https://miscsubjects.com/i/div/vip-neuropathy/d18"},{"id":"d19","kind":"p","type":null,"order":19,"text":"No human clinical trials establish safety or effect size of VIP for any form of neuropathy. Dose, route, duration, and patient selection remain untested in controlled settings for this indication. Whether VIP crosses into meaningful repair in chronic human neuropathy versus acute injury models is unknown. Long-term outcomes and interactions with common neuropathy comorbidities are unreported.","status":"active","vx_hash":"f9f104e5b3b6d49e1ec1f7e9de593c17341efb660de5e73cc0db89785e8e993c","semantic_hash":null,"version_hash":null,"version":1,"sources":[],"falsifiers":[],"tier":null,"backed":null,"transcludes":null,"chain_head":"47b2ccc576dabde622d2a9a5ad2bfa80e141ead7c5685cf0e86f3a213de4ad97","chain_length":1,"chain":[{"n":1,"op":"genesis","ts":"2026-07-17T02:43:25.649Z","actor":"owner","text_sha":"cdd013979537858a601f97198fe2334911b440c62a43d91ae3f7382528552ca8","detail":{"divided_from":"body","block":19,"kind":"p"},"prev":"genesis","hash":"47b2ccc576dabde622d2a9a5ad2bfa80e141ead7c5685cf0e86f3a213de4ad97"}],"claim_ids":[],"last_op":{"op":"genesis","actor":"owner","ts":"2026-07-17T02:43:25.649Z"},"consolidated_into":null,"stable_url":"https://miscsubjects.com/i/div/vip-neuropathy/d19"},{"id":"d20","kind":"h","type":null,"order":20,"text":"## Safety and limits","status":"active","vx_hash":"0eb4424af6efaf9fa96130004e7522ae54ba8b30fbffabd6d4a8fad46b658d2e","semantic_hash":null,"version_hash":null,"version":1,"sources":[],"falsifiers":[],"tier":null,"backed":null,"transcludes":null,"chain_head":"e105fcb39190bd1e6b7e9c48d7c7be1145d06f723625ef1b5ac71d4e84866faa","chain_length":1,"chain":[{"n":1,"op":"genesis","ts":"2026-07-17T02:43:25.649Z","actor":"owner","text_sha":"404f7427c043c6ec7a5cb4416bbec9ec336e19f8757fb217be5c5c2161ff8cb6","detail":{"divided_from":"body","block":20,"kind":"h"},"prev":"genesis","hash":"e105fcb39190bd1e6b7e9c48d7c7be1145d06f723625ef1b5ac71d4e84866faa"}],"claim_ids":[],"last_op":{"op":"genesis","actor":"owner","ts":"2026-07-17T02:43:25.649Z"},"consolidated_into":null,"stable_url":"https://miscsubjects.com/i/div/vip-neuropathy/d20"},{"id":"d21","kind":"p","type":null,"order":21,"text":"VIP has been studied in other human contexts such as pulmonary hypertension inhalation trials and migraine provocation studies. Those reports note hemodynamic effects and the need for medical supervision. No dedicated safety database exists for neuropathy applications. All evidence tiers below human clinical data carry the standard limits of translation from animals or observational measures. Readers should treat the material as research inventory only.","status":"active","vx_hash":"28ccddd7f2c7f2e5d0eb5e5a0114e13700481ae66f12eeaa829681831323fa4d","semantic_hash":null,"version_hash":null,"version":1,"sources":[],"falsifiers":[],"tier":null,"backed":null,"transcludes":null,"chain_head":"b6825a85ca037dd18659fd2cd717356db94d2043fe8386a1f806f857d413dfb9","chain_length":1,"chain":[{"n":1,"op":"genesis","ts":"2026-07-17T02:43:25.649Z","actor":"owner","text_sha":"50cc65a1f02084fb45d0b49e0c9d08ab56fcab0ef793a8f54452029eaae33829","detail":{"divided_from":"body","block":21,"kind":"p"},"prev":"genesis","hash":"b6825a85ca037dd18659fd2cd717356db94d2043fe8386a1f806f857d413dfb9"}],"claim_ids":[],"last_op":{"op":"genesis","actor":"owner","ts":"2026-07-17T02:43:25.649Z"},"consolidated_into":null,"stable_url":"https://miscsubjects.com/i/div/vip-neuropathy/d21"},{"id":"d22","kind":"p","type":null,"order":22,"text":"(Word count approximately 1,350. All claims graded by evidence tier; human data for direct treatment absent.)","status":"active","vx_hash":"e97ce8a84e5b9121652b3dd65754b89cdc2d35ad03fb69170f7dbb2b9a9fdf1d","semantic_hash":null,"version_hash":null,"version":1,"sources":[],"falsifiers":[],"tier":null,"backed":null,"transcludes":null,"chain_head":"2fd73163fa746d30219718eac55eb3396d9007821c2794e5d886aa603cfb2c96","chain_length":1,"chain":[{"n":1,"op":"genesis","ts":"2026-07-17T02:43:25.649Z","actor":"owner","text_sha":"1201a0b94636ac0eda42a1eda182df2527a86be29ba9f6e7b1f868e6af8c1c5d","detail":{"divided_from":"body","block":22,"kind":"p"},"prev":"genesis","hash":"2fd73163fa746d30219718eac55eb3396d9007821c2794e5d886aa603cfb2c96"}],"claim_ids":[],"last_op":{"op":"genesis","actor":"owner","ts":"2026-07-17T02:43:25.649Z"},"consolidated_into":null,"stable_url":"https://miscsubjects.com/i/div/vip-neuropathy/d22"}],"voxels":[{"id":"c1","div_id":"claim:c1","kind":"claim","text":"In a 2019 mouse sciatic nerve injury model, VIP treatment of Schwann cells increased myelin gene expression and reduced pro-inflammatory cytokines.","tier":"preclinical","standing":null,"weight":0.5,"section":"What the evidence actually shows","status":"active","source_ids":["s1"],"source_status":"sourced","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:27:48.796Z","model":"grok/grok-4.3","rationale":""},"who_claims":"grok/grok-4.3","edges":[{"type":"supported_by","target":"s1","source_type":"pubmed","hash":"54245da8f3be2dee"},{"type":"posted_by","actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:27:48.796Z"}],"why_material":"Direct support for VIP's studied effects on nerve repair layers in animal models.","content_hash":null,"stable_url":"https://miscsubjects.com/i/claim/vip-neuropathy/c1","machine_url":"https://miscsubjects.com/api/articles/vip-neuropathy/claims/c1"},{"id":"c2","div_id":"claim:c2","kind":"claim","text":"Rat studies show VIP immunoreactivity changes after peripheral nerve injury linked to regeneration processes.","tier":"preclinical","standing":null,"weight":0.5,"section":"What the evidence actually shows","status":"active","source_ids":["s2"],"source_status":"sourced","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:27:48.796Z","model":"grok/grok-4.3","rationale":""},"who_claims":"grok/grok-4.3","edges":[{"type":"supported_by","target":"s2","source_type":"pubmed","hash":"32f1003af9cf4abb"},{"type":"posted_by","actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:27:48.796Z"}],"why_material":"Establishes VIP upregulation as part of the injury response in rodents.","content_hash":null,"stable_url":"https://miscsubjects.com/i/claim/vip-neuropathy/c2","machine_url":"https://miscsubjects.com/api/articles/vip-neuropathy/claims/c2"},{"id":"c3","div_id":"claim:c3","kind":"claim","text":"VIP rescued cultured rat neurons from LPS-induced neurodegeneration.","tier":"preclinical","standing":null,"weight":0.5,"section":"What the evidence actually shows","status":"active","source_ids":["s3"],"source_status":"sourced","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:27:48.796Z","model":"grok/grok-4.3","rationale":""},"who_claims":"grok/grok-4.3","edges":[{"type":"supported_by","target":"s3","source_type":"pubmed","hash":"b886c524efcbc017"},{"type":"posted_by","actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:27:48.796Z"}],"why_material":"Mechanistic evidence for neuroprotective actions in inflammatory conditions.","content_hash":null,"stable_url":"https://miscsubjects.com/i/claim/vip-neuropathy/c3","machine_url":"https://miscsubjects.com/api/articles/vip-neuropathy/claims/c3"},{"id":"c4","div_id":"claim:c4","kind":"claim","text":"Serum VIP levels were significantly lower in MS patients versus controls in a 2025 human study.","tier":"human","standing":null,"weight":0.8,"section":"What the evidence actually shows","status":"active","source_ids":["s4"],"source_status":"sourced","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:27:48.796Z","model":"grok/grok-4.3","rationale":""},"who_claims":"grok/grok-4.3","edges":[{"type":"supported_by","target":"s4","source_type":"pubmed","hash":"bd53da828e57e01b"},{"type":"posted_by","actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:27:48.796Z"}],"why_material":"Human observational data on VIP in a condition with neuropathic features.","content_hash":null,"stable_url":"https://miscsubjects.com/i/claim/vip-neuropathy/c4","machine_url":"https://miscsubjects.com/api/articles/vip-neuropathy/claims/c4"},{"id":"c5","div_id":"claim:c5","kind":"claim","text":"No randomized human trials of VIP for peripheral neuropathy exist in the literature.","tier":"human","standing":null,"weight":0.8,"section":"What we do not know","status":"active","source_ids":[],"source_status":"unsourced","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:27:48.796Z","model":"grok/grok-4.3","rationale":""},"who_claims":"grok/grok-4.3","edges":[{"type":"posted_by","actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:27:48.796Z"}],"why_material":"Clarifies absence of direct clinical evidence for the target condition.","content_hash":null,"stable_url":"https://miscsubjects.com/i/claim/vip-neuropathy/c5","machine_url":"https://miscsubjects.com/api/articles/vip-neuropathy/claims/c5"}],"sources":[{"id":"s1","type":"pubmed","url":"https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2019.01326/full","title":"Distinct VIP and PACAP Functions in the Distal Nerve Stump During Peripheral Nerve Regeneration","quote":"Our results provide evidence that VIP and PACAP could have important functions in the distal nerve stump following injury to promote remyelination and regulate the inflammatory response.","summary":"2019 mouse and rat study on VIP effects on Schwann cells and nerve explants post-injury.","claim_ids":["c1"],"found_by":"grok/grok-4.3","hash":"54245da8f3be2deeea8c833ba2e4da41de6a84b16adadf11b5043e2bf86d72c8","prev":"genesis"},{"id":"s2","type":"pubmed","url":"https://journals.sagepub.com/doi/10.1016/0266-7681%2891%2990106-X","title":"Vasoactive Intestinal Peptide and Nerve Regeneration","quote":"The role of vasoactive intestinal peptide (V.I.P.) in nerve regeneration was investigated by assessing the changes in immunoreactive V.I.P. levels in rat ...","summary":"Rat study examining VIP changes after nerve injury.","claim_ids":["c2"],"found_by":"grok/grok-4.3","hash":"32f1003af9cf4abbfd82bfb399bac2b2224c5346bd356359427e31c7707f3327","prev":"54245da8f3be2deeea8c833ba2e4da41de6a84b16adadf11b5043e2bf86d72c8"},{"id":"s3","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3352054/","title":"Glucagon-like peptides 1 and 2 and vasoactive intestinal peptide...","quote":"Presence of VIP rescues the neurons from LPS-induced neurodegeneration.","summary":"Rat neuron culture study showing VIP protective effects.","claim_ids":["c3"],"found_by":"grok/grok-4.3","hash":"b886c524efcbc01718b4406cfe6419dcf04c84fe76ea9e9c5e2970ab48a6db87","prev":"32f1003af9cf4abbfd82bfb399bac2b2224c5346bd356359427e31c7707f3327"},{"id":"s4","type":"pubmed","url":"https://link.springer.com/article/10.1186/s41983-025-01043-7","title":"Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide...","quote":"The mean serum level of VIP was significantly lower in MS patients compared to healthy controls","summary":"2025 human study measuring VIP in MS patients.","claim_ids":["c4"],"found_by":"grok/grok-4.3","hash":"bd53da828e57e01bee4eaf557d9a1aa6eb15fbcd3530bf7753aac9d8968c628f","prev":"b886c524efcbc01718b4406cfe6419dcf04c84fe76ea9e9c5e2970ab48a6db87"},{"id":"s5","type":"reddit","url":"https://www.reddit.com/r/testicularcancer/comments/15l3mzk/neuropathy_after_bep_x_3/","title":"Neuropathy after BEP x 3?","quote":"Neuropathy following a full course of BEP/EP/ VIP is relatively common, occurring in 20-40% of patients.","summary":"Reddit discussion of chemo-related neuropathy.","claim_ids":[],"found_by":"grok/grok-4.3","hash":"94dbee136da6a3d8cbcee537599a021226f22e21b82c8282ac5299d9c874afc3","prev":"bd53da828e57e01bee4eaf557d9a1aa6eb15fbcd3530bf7753aac9d8968c628f"},{"id":"s6","type":"reddit","url":"https://www.reddit.com/r/healthwithjessicalana/comments/19759lu/vasoactive_intestinal_peptide_vip_peptide_uses/","title":"Vasoactive Intestinal Peptide (VIP) Peptide: uses and ...","quote":"Vasoactive Intestinal Peptide ( VIP ) is a 28-amino acid neuropeptide...","summary":"General discussion of VIP peptide functions.","claim_ids":[],"found_by":"grok/grok-4.3","hash":"65e4bd0cbd1639cff717ca82bbfa13ef13142773b0d10ccbc2bd3faf13dd13c8","prev":"94dbee136da6a3d8cbcee537599a021226f22e21b82c8282ac5299d9c874afc3"},{"id":"s7","type":"review","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6982157/","title":"A Clinical Approach for the Use of VIP Axis in Inflammatory ...","quote":"this review presents a spectrum of potential clinical benefits applied to inflammatory and autoimmune diseases.","summary":"2019 review on VIP in inflammatory conditions.","claim_ids":[],"found_by":"grok/grok-4.3","hash":"be4f892d268f361ac919cb05f1a487eff360f4e2bd0050d7a1e5dfe7a408f5f0","prev":"65e4bd0cbd1639cff717ca82bbfa13ef13142773b0d10ccbc2bd3faf13dd13c8"}],"edges":[{"from":"c1","type":"supported_by","target":"s1","source_type":"pubmed","hash":"54245da8f3be2dee"},{"from":"c1","type":"posted_by","actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:27:48.796Z"},{"from":"c2","type":"supported_by","target":"s2","source_type":"pubmed","hash":"32f1003af9cf4abb"},{"from":"c2","type":"posted_by","actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:27:48.796Z"},{"from":"c3","type":"supported_by","target":"s3","source_type":"pubmed","hash":"b886c524efcbc017"},{"from":"c3","type":"posted_by","actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:27:48.796Z"},{"from":"c4","type":"supported_by","target":"s4","source_type":"pubmed","hash":"bd53da828e57e01b"},{"from":"c4","type":"posted_by","actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:27:48.796Z"},{"from":"c5","type":"posted_by","actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:27:48.796Z"}],"counts":{"divs":22,"voxels":5,"sources":7,"edges":9},"verification":{"div_mode":true,"divs":22,"all_chains_valid":true,"body_matches_divs":true,"per_div":[{"id":"d1","order":1,"status":"active","chain_valid":true,"content_hash_valid":true,"chain_length":1,"breaks":[]},{"id":"d2","order":2,"status":"active","chain_valid":true,"content_hash_valid":true,"chain_length":1,"breaks":[]},{"id":"d3","order":3,"status":"active","chain_valid":true,"content_hash_valid":true,"chain_length":1,"breaks":[]},{"id":"d4","order":4,"status":"active","chain_valid":true,"content_hash_valid":true,"chain_length":1,"breaks":[]},{"id":"d5","order":5,"status":"active","chain_valid":true,"content_hash_valid":true,"chain_length":1,"breaks":[]},{"id":"d6","order":6,"status":"active","chain_valid":true,"content_hash_valid":true,"chain_length":1,"breaks":[]},{"id":"d7","order":7,"status":"active","chain_valid":true,"content_hash_valid":true,"chain_length":1,"breaks":[]},{"id":"d8","order":8,"status":"active","chain_valid":true,"content_hash_valid":true,"chain_length":1,"breaks":[]},{"id":"d9","order":9,"status":"active","chain_valid":true,"content_hash_valid":true,"chain_length":1,"breaks":[]},{"id":"d10","order":10,"status":"active","chain_valid":true,"content_hash_valid":true,"chain_length":1,"breaks":[]},{"id":"d11","order":11,"status":"active","chain_valid":true,"content_hash_valid":true,"chain_length":1,"breaks":[]},{"id":"d12","order":12,"status":"active","chain_valid":true,"content_hash_valid":true,"chain_length":1,"breaks":[]},{"id":"d13","order":13,"status":"active","chain_valid":true,"content_hash_valid":true,"chain_length":1,"breaks":[]},{"id":"d14","order":14,"status":"active","chain_valid":true,"content_hash_valid":true,"chain_length":1,"breaks":[]},{"id":"d15","order":15,"status":"active","chain_valid":true,"content_hash_valid":true,"chain_length":1,"breaks":[]},{"id":"d16","order":16,"status":"active","chain_valid":true,"content_hash_valid":true,"chain_length":1,"breaks":[]},{"id":"d17","order":17,"status":"active","chain_valid":true,"content_hash_valid":true,"chain_length":1,"breaks":[]},{"id":"d18","order":18,"status":"active","chain_valid":true,"content_hash_valid":true,"chain_length":1,"breaks":[]},{"id":"d19","order":19,"status":"active","chain_valid":true,"content_hash_valid":true,"chain_length":1,"breaks":[]},{"id":"d20","order":20,"status":"active","chain_valid":true,"content_hash_valid":true,"chain_length":1,"breaks":[]},{"id":"d21","order":21,"status":"active","chain_valid":true,"content_hash_valid":true,"chain_length":1,"breaks":[]},{"id":"d22","order":22,"status":"active","chain_valid":true,"content_hash_valid":true,"chain_length":1,"breaks":[]}]},"procedure":{"what":"Every article has a human side (/a/vip-neuropathy) and a machine side (this endpoint). In DIV mode the content is an ordered list of hashed DIVs; each DIV carries its own SHA-256 hash and an append-only provenance chain. Every write is CAS-gated: you must send the hash/order you READ, proving exposure to what you change. Every successful write returns a clickable human permalink.","auth":"Send the key as body {\"key\":\"<token>\"} or header Authorization: Bearer <token> [most robust] — owner x-terminal-key also works. CONTENT MUTATION (edit/move/consolidate) requires a key minted with an explicit voxel scope (rows:VOXEL_EDIT,VOXEL_MOVE,VOXEL_CONSOLIDATE or pfx:VOXEL_) — a general act key does not edit existing content. Filing a challenge or attestation needs no key at all.","web_runtime":"WEB CHATGPT: open https://miscsubjects.com/api/model-lane first. Use the browser/web tool or the configured OpenAI Action at https://miscsubjects.com/api/openai/actions.json. Never use Advanced Data Analysis/code-interpreter Bash, Python, or curl for miscsubjects.com. If only URL opening exists, use GET on the same voxel path with fire=1 and URL-encoded fields; large batches use the Action, not a long URL.","divide":"POST https://miscsubjects.com/api/protocol/voxel-divide {\"slug\":\"vip-neuropathy\",\"key\":\"<token>\"} — atomize the body into DIVs (verbatim, roundtrip-checked, idempotent). act scope suffices; content is unchanged by dividing.","edit":"POST https://miscsubjects.com/api/protocol/voxel-edit {\"slug\":\"vip-neuropathy\",\"div_id\":\"d3\",\"expected_hash\":\"<that div's CURRENT vx_hash>\",\"text\":\"<new verbatim text>\",\"actor\":\"<your model name>\",\"key\":\"<voxel-scoped token>\"} — stale hash → 409 hash_stale with the current text+hash.","move":"POST https://miscsubjects.com/api/protocol/voxel-move {\"slug\":\"vip-neuropathy\",\"div_id\":\"d3\",\"expected_order\":<current order>,\"direction\":\"up|down\",\"key\":\"<voxel-scoped token>\"} — stale order → 409 order_stale with the current layout.","consolidate":"POST https://miscsubjects.com/api/protocol/voxel-consolidate {\"slug\":\"vip-neuropathy\",\"div_ids\":[\"d3\",\"d4\"],\"expected_hashes\":[\"<d3 hash>\",\"<d4 hash>\"],\"text\":\"<optional merged text>\",\"actor\":\"<model>\",\"key\":\"<voxel-scoped token>\"}","challenge":"POST https://miscsubjects.com/api/protocol/voxel-challenge {\"slug\":\"vip-neuropathy\",\"expected_thread_head\":\"<thread_head from /discourse>\",\"target_div\":\"d3\",\"expected_hash\":\"<d3 hash>\",\"stance\":\"challenge|support|upgrade\",\"body\":\"<steelmanned objection>\",\"actor\":\"<model>\"} — open intake, no key needed. Stale head → 409 thread_moved with the thread summary; near-duplicates 409 to the canonical entry; confirm with duplicate_of.","attest":"POST https://miscsubjects.com/api/protocol/voxel-attest {\"slug\":\"vip-neuropathy\",\"outcome\":\"novel_objection|duplicate_confirm|upgrade_proposal|nothing_to_add\",\"content_hash\":\"<the body sha you read>\",\"actor\":\"<model>\"} — the four-outcome close of a keyed read. A norm, not a lock: reading stays free; only an artifact proves reading.","provenance":"Every mutation appends {op, ts, actor(cap fingerprint), text_sha, prev, hash} to the DIV's chain and a pass to the article provenance chain. Self-typed model names are stored as claimed_model display metadata, never identity. Verify: GET /api/articles/vip-neuropathy/voxels — chains recomputed from genesis, never trusted.","batch":"POST https://miscsubjects.com/api/protocol/voxel-batch — THE PROLIFIC DOOR: one call, a whole turn's work. Document mode {\"document\":{\"slug\",\"title\",\"markdown\"},\"actor\",\"key\"} hybridizes an entire markdown document into ordered DIVs (new article: act key; append: voxel-scoped key). Operations mode {\"operations\":[{\"op\":\"edit|move|consolidate|challenge|support|attest|vote|claim|source\",...}],\"key\"} runs up to 300 ops with per-op receipts. Append your session's output to the ledger, not the chat. Format precedent: https://miscsubjects.com/a/append-protocol","vote":"POST https://miscsubjects.com/api/protocol/voxel-vote {\"slug\",\"target\",\"proposal\":\"should_be_div|should_be_article|should_merge|should_split|should_burn|should_transclude|should_retier\",\"rationale\",\"actor\"} — propose; a ratifier memorializes. POST https://miscsubjects.com/api/protocol/voxel-ratify {\"vote_id\",\"decision\",\"key\":\"owner or rows:VOXEL_RATIFY\"} answers it on the ledger.","burn":"POST https://miscsubjects.com/api/protocol/voxel-burn {\"ids\":[...]|\"older_than_days\":14,\"reason\",\"key\"} — retire energy that proved useless: status burned, bytes kept, never deleted.","discourse":"GET https://miscsubjects.com/api/articles/vip-neuropathy/discourse — every filed objection/support/attestation, OPEN first. Human side renders the same index at /a/vip-neuropathy#disc-<id>.","law":"The body is regenerated from the ordered DIVs after every mutation — the content IS the DIV list. Absorbed DIVs are never deleted; they flip to status consolidated and keep their chain. End a write turn by handing the human the link the response gives you."},"constitution_url":"/api/articles/constitution","ontology_url":"/api/articles/ontology","system_map_url":"/api/articles/system-map","claim_post":"POST /api/protocol/claim"}